Progressive Fibrosing Interstitial Lung Disease (PF-ILD) – Policy Roundtable
The Institute for Health Economics (IHE) is conducting an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable will seek to gain multi-stakeholder consensus on policy recommendations intended to optimize care for PF-ILD patients
Key areas for discuss are in the following three areas:
- Multi-disciplinary PF-ILD guidelines
- Education/awareness initiatives for primary care providers and policy makers
- Optimal models of multidisciplinary care centres of excellence
The purpose of this discussion will be to bring together multiple stakeholders from across Canada to investigate the current state of evidence and information regarding PF-ILD idiopathic pulmonary fibrosis (IPF) and provide recommendations regarding special considerations for policy making and healthcare decision-making. This invitational forum is being organized by the Institute of Health Economics (IHE) and is supported by and developed in partnership with Boehringer Ingelheim (Canada) Ltd./Ltée.